Current Assets
Other current assets
Royalty Pharma Other current assets increased by 47.4% to $10.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 230.0%, from $3.08M to $10.16M. Over 5 years (FY 2020 to FY 2025), Other current assets shows a downward trend with a -4.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
Detailed definition
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Peer comparison
Standard across all industries; usually a minor component of the balance sheet.
Metric ID:
current_assets_other_assets_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.10M | $8.95M | $6.63M | $5.39M | $67.12M | $90.52M | $90.52M | $4.57M | $10.22M | $6.78M | $18.04M | $5.01M | $2.29M | $4.97M | $4.19M | $3.08M | $4.45M | $5.52M | $6.89M | $10.16M |
| QoQ Change | — | -26.1% | -25.9% | -18.7% | >999% | +34.9% | +0.0% | -95.0% | +123.7% | -33.6% | +165.9% | -72.2% | -54.3% | +116.8% | -15.7% | -26.5% | +44.6% | +24.0% | +24.9% | +47.4% |
| YoY Change | — | — | — | — | +454.8% | +911.9% | >999% | -15.2% | -84.8% | -92.5% | -80.1% | +9.6% | -77.6% | -26.8% | -76.8% | -38.5% | +94.2% | +11.1% | +64.6% | +230.0% |
Range$2.29M – $90.52M
CAGR-3.6%
Avg YoY Growth+159.3%
Median YoY Growth-2.8%
Current Streak4 quarters growth
Other current assets at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's other current assets?
- Royalty Pharma (RPRX) reported other current assets of $10.16M in Q1 2026.
- How has Royalty Pharma's other current assets changed year-over-year?
- Royalty Pharma's other current assets increased by 230.0% year-over-year, from $3.08M to $10.16M.
- What is the long-term trend for Royalty Pharma's other current assets?
- Over 5 years (2020 to 2025), Royalty Pharma's other current assets has grown at a -4.3% compound annual growth rate (CAGR), from $8.60M to $6.89M.
- What does other current assets mean?
- Miscellaneous current assets that do not fall into standard categories like cash or inventory.